12 Biggest Mid-Day Gainers For Tuesday - Abeona Therapeutics (NASDAQ:ABEO)

Juno Therapeutics Inc JUNO shares climbed 19 percent to $43.38. Raymond James upgraded Juno Therapeutics from Market Perform to Outperform, while Wedbush upgraded the stock from Neutral to Outperform.
Movado Group, Inc MOV shares jumped 17.9 percent to $28.15 after the company posted better-than-expected results for its second quarter and raised its FY 2018 forecast.
Catalent Inc CTLT shares surged 15.7 percent to $40.92 as the company reported stronger-than-expected results for its fourth quarter on Monday.
ImmunoGen, Inc. IMGN gained 13.9 percent to $7.33. Jazz Pharma and ImmunoGen disclosed an agreement granting Jazz worldwide rights to opt into development and commercialization of 2 early stage drugs.
Moleculin Biotech Inc MBRX shares climbed 13.8 percent to $2.66 after the company disclosed that it has filed an investigational NDA with the FDA for Annamycin.
Atwood Oceanics, Inc. ATW shares gained 13.2 percent to $7.14.
Sterling Construction Company, Inc. STRL shares rose 10 percent to $11.91.
Internet Initiative Japan Inc. (ADR) IIJI shares gained 8.4 percent to $9.29.
AcelRx Pharmaceuticals Inc ACRX shares climbed 7.4 percent to $3.28.
The Advisory Board Company ABCO gained 6.3 percent to $52.97 as the company agreed to sell health care and education businesses for $2.58 billion.
Abeona Therapeutics Inc ABEO rose 5.7 percent to $10.04 as the company disclosed that it has received the FDA Breakthrough Therapy designation for EB-101 autologous cell therapy in Epidermolysis Bullosa.
DarioHealth Corp DRIO gained 3.7 percent to $2.07. Aegis Capital initiated coverage on DarioHealth with a Buy rating.

Market News and Data brought to you by Benzinga APIs